✦ LIBER ✦

Lymphokine-activated killer cell susceptibility in epirubicin-resistant and parental human non-small cell lung cancer (NSCLC)

✍ Scribed by Aysun Ozkan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined effect of cisplatin and lymphok

✍ O. S. Zhukova; G. K. Gerasimova; I. Zh. Shubina; M. V. Kiselevskii 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 554 KB

Phase II trial of high dose epirubicin a

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Lymphocyte subsets and natural killer ce

✍ Elfiky, A.; Shehata, M.Ábo; Salama, O.S.; Khaled, A.; El-Dewairy, S. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Reduced topoisomerase II activity in mul

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Generation and expansion of lymphokine-a

✍ Yano, Tokujiro; Yasumoto, Kosei; Nomoto, Kikuo 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 714 KB

Generation and expansion of lymphokine-a

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 162 KB